Objectives To explore the impact of severity and management (expectant, laser treatment, or selective reduction) on perinatal outcome of monochorionic twin pregnancies complicated by selective intrauterine growth restriction (sFGR). Methods A comprehensive literature search was performed. The primary outcome was mortality. The secondary outcomes were neonatal morbidity and survival free from neurological complications (intact survival).
Results Fifteen observational studies (784 pregnancies) were included. In type 1 sFGR managed expectantly, 97.9% (95% CI 93.6-99.9) had intact survival, with few cases of fetal intervention reported. In type 2 managed expectantly, IUD occurred in 16.6% (95% CI 6.9-29.5) and intact survival was 89.3% (95% CI 71.8-97.7). With laser, IUD was 44.3% (95% CI 22.2-67.7), and all survivors were neurologically intact. In selective reduction, co-twin IUD occurred in 5.0% (95% CI 0.03-20.5) and there was 90.6% 3) intact survival. In type 3 managed expectantly, IUD occurred in 13.2% (95% CI 7.2-20.5) and 61.9% (95% CI 38.4-81.9) had intact survival. After laser, IUD occurred in 32.9% (95% CI 20.9-46.2) and all survivors were intact. After selective reduction, 98.8% (95% CI 93.9-99.9) had intact survival. Conclusions Type 1 sFGR expectantly managed is characterised by good perinatal outcome. Pregnancies complicated by types 2 and 3 treated with laser had higher mortality but lower morbidity compared with expectant management, supporting the use of fetal therapy at early gestations. In view of the lack of RCT evidence, management of sFGR should be individualised according to gestational age at diagnosis, severity of growth discordance, and magnitude of Doppler abnormalities.
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Fetal growth in twins: comparison of twin-specific STORK and singleton customised GROW charts Francis, A; Hugh, O; Gardosi, J Perinatal Institute, Birmingham, UK Objective We wanted to assess whether the STORK twin standard or the customised GROW chart for singleton pregnancies best reflects fetal growth in a cohort of normal twin pregnancies. Design Retrospective analysis of estimated fetal weight (EFW) recorded in serially scanned twin pregnancies. Method The original cohort consisted of 105 twin pregnancies with spontaneous onset of labour, gestation at delivery ≥ 34 weeks, twintwin discordance less than 15%, and normal perinatal outcome. Fetal growth curves were derived by log quadratic fit, for the first twin only, in 98 pregnancies which had two or more third-trimester EFWs recorded (mean: 4.1, SD: 1.0). The individually fitted curves were averaged to derive a fetal weight standard based on this normal twin cohort (NTC) and compared with: 1. the dichorionic twin-specific charts derived by the South West Thames Obstetric Collaborative (STORK), which is based on whole population reference values and includes both twins; and 2. the singleton pregnancy-based GROW (gestation-related optimal weight) charts, adjusted for the usual set of maternal characteristics in the twin cohort. Results Comparative analysis of both standards with the NTC curve showed that STORK was significantly below NTC throughout gestation, while the GROW standard followed it more closely: at 34.0 weeks: NTC 2396 g, STORK 2175 g (À221 g, À9.2%), GROW 2337 g (À59 g, À2.5%), P < 0.01; 37.0 weeks: NTC 2958 g, STORK 2696 g (À262 g, À8.8%), GROW 2977 g (+19 g, +0.6%), P < 0.01. Conclusion Customised singleton GROW charts represent normal growth in twin pregnancy better than the STORK twin-specific, population-based reference charts.
socio-political climate surrounding prenatal testing and how this impacts on women's decision-making and clinical care. ARC has been providing independent nondirective information and support to women and couples through antenatal screening and its consequences for 30 years. In the last five years, we have noted a cultural change in this ethically charged area. Both disability rights activists and anti-abortion campaigners have sought to critique antenatal screening as eugenic and the option to terminate as discriminatory to people living with disabilities. The 2017 Nuffield Council on Bioethics Working Group Report on noninvasive prenatal testing took up some of these arguments. This paper will explore the current arguments and trace some of the effects they have had on policy and practice and on the context for women and couples making choices through the screening process. Recommendations will be made regarding how we can best address some of the concerns but also remain robust in supporting women and their partners to make the informed choices that are appropriate to their individual circumstances.
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Implementation of dedicated Multiple Births Clinics in a large District General Hospital Mukherjee, S; Lees, K Queen Alexandra Hospital, Portsmouth, UK Objectives We aimed to implement a one-stop Multiple Births Clinic at Queen Alexandra Hospital in Portsmouth. This was to accommodate an increasing number of multiple births and to provide a specialist multidisciplinary approach to management of these high-risk pregnancies to reduce the risk of stillbirth, preterm delivery, and maternal comorbidity. This clinic would fit with national guidance (NICE) for antenatal care of multiple pregnancy. Design The plan was to achieve multidisciplinary care within the clinic including same day consultant review and discussion of the (NICE) antenatal pathway by a specialist midwife. We also wanted to set up specialist twin antenatal classes to allow for increased peer support. It was also important to provide support for mental health. Method We introduced local guidelines and streamlined referral procedures allowing patients review in clinic after confirmation on ultrasound of a multiple pregnancy, including referral to FMU if MC twins or higher order pregnancy was confirmed. We trained a specialist MDT to care for the women allowing continuity of care. We are conducting an audit and patient satisfaction survey to demonstrate improvements in quality of care. Results This clinic is providing women with high-quality MDT care, a peer group support network, and support from tertiary centres when required. Conclusions The clinic has improved the quality of care in this group of women. It is achieving high patient satisfaction and is showing a reduction in complication rates. We are aiming to be involved in more research, and training and audit projects locally and nationally. Objective To compare birthweight growth charts in relation to perinatal mortality and explore different thresholds associated with increased risk. Design Population-based cohort study using Swedish Medical Birth Registry. Method Women who gave birth at term of singletons between 2006 and 2015 were included, restricted to those with data on first-trimester combined screening. Risk of perinatal mortality was explored in relation to three birthweight growth charts: population, customised, and Intergrowth centiles. Risk was assessed in intervals of 5 centiles with the reference group being the 40th-60th centile. Logistic regression was used to explore associations. Sensitivity for fixed false-positive rates (FPR) was reported.
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Results Among 212,101 women, prevalence of SGA (<10th centile) was 10.1%, 10.5%, and 3.1% for population, customised and Intergrowth centiles, respectively. Risk of perinatal mortality was consistently increased below the 15th, 10th, and 35th centiles for each chart, respectively. Prevalence of LGA (>90th centile) was 10.0%, 8.3%, and 25.1%, respectively. In large infants, perinatal mortality was only associated with customised centiles (>95th centile). For fixed FPR of 10%, different thresholds for each chart achieved similar sensitivity for perinatal mortality in small (29% for all charts) and large babies (9%, 10%, and 7% for population, customised, and Intergrowth centiles, respectively). Conclusion The centile threshold associated with increased risk of perinatal mortality is different according to the chart used for both large and small infants. The performance of these growth charts is similar in relation to the association with and sensitivity for perinatal mortality once different thresholds account for fixed FPR.
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Idiopathic polyhydramnios at term -management and outcomes Timmons, P; Malakasis, A; Smith, R Methods Severity of polyhydramnios graded by DVP measurement:
Mild: 8-11 cm Moderate: 12-15 cm Severe: >15 cm Data were collected from 145 cases of idiopathic polyhydramnios in normally grown infants (customised centiles), diagnosed at >34/40 on: timing of diagnosis; timing of delivery; onset of labour; and neonatal outcomes. Results One hundred and forty-five cases of idiopathic polyhydramnios were diagnosed from a total of 5599 births, representing 2.6% of all births and 50.5% of all polyhydramnios diagnoses (90% mild, 9% moderate, 1% severe). Thirteen percent of cases where polyhydramnios was present at 36/40 resolved spontaneously on follow-up scan. Fifty percent of patients underwent induction of labour <39/40, rising to 71% thereafter. Thirteen infants required neonatal unit admission (three anticipated due to prematurity). All infants had Apgar scores of 9 or more at 5 minutes. No cases of cord prolapse occurred. One intrauterine fetal death was recorded. Conclusion These results demonstrate a tendency towards routine induction of labour for idiopathic polyhydramnios prior to 40/40 despite a lack of evidence to support such practice and highlight the need for a guideline to aid decision-making. The significant number of cases which resolved spontaneously may suggest a role for repeat ultrasound at an appropriate interval in the absence of any additional concerns.
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The uptake of routinely offered whooping cough vaccination in pregnancy Rainey, L 1 ; Wisdom, S 2 1 Royal Jubilee Maternity Hospital, Belfast, UK; 2 Dumfries & Galloway Royal Infirmary, Dumfries, UK Objectives Infants in the first few months of life are the group most at risk of morbidity and death from whooping cough. After a rise in whooping cough incidence, whooping cough vaccination (WCV) is now offered to all pregnant women in the UK to provide passive immunity for the baby. This audit aimed to determine the proportion of pregnant women who received WCV and, if not, the reasons why not. Design Questionnaires about their participation in the antenatal WCV programme were completed for women giving birth at term gestations. Methods Qualifying women in one Obstetric Unit in Scotland were approached on random days until 100 questionnaires were completed. Whether they had wanted and received WCV was recorded. If WCV was not wanted/received, the reason was noted. Primary Health Care Records were examined to confirm vaccination information. Results Information from Primary Health Care on vaccination status was not received for 11 women. These cases have been excluded. Of the 89 women with confirmed data, 71 (80%) received WCV (although beyond the recommended gestational period in four cases) and 18 (20%) did not. Of the 18 women who did not receive WCV, five had not wanted it, three missed or did not arrange the appointment, one had no antenatal care, and six thought they had received it. Conclusions The confirmed uptake of WCV was 80%. This will likely be increased with the administration of WCV being moved from the Primary Health Care Team to the midwifery service.
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Fetal growth trajectory assessed by customised limits and adverse perinatal outcome Francis, A; Hugh, O; Gardosi, J Perinatal Institute, Birmingham, UK Objective Slow growth is associated with adverse perinatal outcome. We wanted to assess the predictive value of fetal growth trajectories when measured against optimal growth as defined by customised charts. Design Retrospective cohort study of routinely collected regional data (n = 174,617). Method The cohort included 11,488 pregnancies with at least 2 third-trimester scans (median 28.4 and 36.6 weeks). Each set of estimated fetal weights was curve-fitted and compared with the normal growth trajectory predicted by customised GROW charts. Outcomes were as follows: (1) emergency caesarean section (EmCS, n = 1195), (2) composite (Comp) of Apgar score <7 at 5 minutes and/or admission to neonatal unit (n = 270), and (3) perinatal death (n = 31). Results Normal growth characterised as trajectories within the interquartile range (25th-75th) on the GROW chart had a protective effect for EmCS (RR 0.64, and Comp (0.67, , and no significant association with perinatal death (1.06, 0.51-2.18). Pregnancies with growth trajectories reflecting the 10th centile were not at increased risk; however, once the slope of the curve was less than 90% of the slope of the 10th centile line, there was an increased risk of EmCS (1.51, 1.21-1.87), Comp (1.91, and perinatal death (3.63, ). Almost a third (32.1%) of fetuses with slow growth and adverse outcome were not SGA at birth. Conclusion Normal fetal growth as predicted by GROW charts is protective, while growth trajectories slower than that defined by the 10th customised centile, regardless whether they are SGA at birth, are associated with adverse perinatal outcome.
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Outcomes of monochorionic diamniotic twin pregnancies in a District General Hospital Beaumont, D; Dieh, A selective intrauterine growth restriction (sIUGR) and twin-to-twin transfusion syndrome (TTTS) and premature delivery. We set out to examine the outcomes of these pregnancies in our unit. Method Retrospective data collection from women carrying MCDA twins who were delivered between March 2016 and October 2018. The patients were identified from the antenatal clinic records. All data were then collected with information gathered from the local maternity database. Results In the 31-month period, 33 sets of MCDA twins were cared for and delivered in our unit. There were four cases (12%) of antenatal and one case of acute intrapartum TTTS. Three women with early TTTS were referred to fetal medicine unit with facilities for fetoscopic laser ablation (FLA) for further management. sIUGR affect nine (27%) pregnancies. Some were referred to the tertiary fetal medicine unit for initial assessment following which they were managed locally. Average gestation at delivery was 34 + 6 weeks. Vaginal delivery occurred in 31%, planned caesarean section in 38%, and emergency caesarean section in 31%. Thirty-four babies were admitted to the neonatal unit, for a total of 772 days. There were two neonatal deaths due to complications of TTTS. Conclusion With local expertise in fetal medicine scanning and the support of tertiary fetal medicine unit, MCDA pregnancies can be managed in a DGH maternity. There is a need for good local neonatal support as these pregnancies place a significant workload on neonatal care.
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Fetal anomaly screening programme detection rates for Bradford Teaching Hospitals NHS Foundation Trust from the National congenital anomaly and rare disease registration service (NCARDRS) Belchita, A; Jones, V; Munjuluri, P Bradford Teaching Hospitals, Bradford, UK Objectives Women can make a choice to have fetal anomaly screening between 18 and 23 weeks of pregnancy. NCARDRS aims are to help maternity services improve the information given to women and their families on which to base their choices. It provides useful data to trusts to support them in delivering highquality services. Methods The performance against the national and regional target detection rates was evaluated between 2016 and 2017 for 62 complete cases. The conditions screened for during the fetal anomaly ultrasound scan are: anencephaly, bilateral renal agenesis, cleft lip +/À palate, congenital diaphragmatic hernia, exomphalos, gastroschisis, lethal skeletal dysplasia, serious cardiac, spina bifida, trisomy 13, and trisomy 18. There are four serious cardiac anomalies screened for: transposition of the great arteries, atrioventricular septal defect, tetralogy of Fallot, and hypoplastic left heart syndrome. The target detection rates for laboratory screening (combined and quadruple test) for trisomy 21 were also analysed.
Results Programme targets were achieved for: trisomy 18, spina bifida, serious cardiac except for transposition of the great arteries, lethal skeletal dysplasia, gastroschisis, congenital diaphragmatic hernia, and cleft lip +/À palate. Targets for trisomy 13 were not met, but this was based on one case only. There were no complete eligible cases to audit for exomphalos, bilateral renal agenesis, and anencephaly. Conclusion It is essential that our trust maximises the quality and completeness of cases notified to NCARDRS by raising it on the agenda of antenatal screening groups, delivery suite staff meetings, neonatal/paediatric teams and reporting the cleft lip +/À palate defects.
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To measure or not to measure -NCHD current practice of abdominal circumference (AC) measurement in Antenatal Clinic (ANC) in Cork University Maternity Hospital (CUMH) and the level of training required in achieving international best practice Enright, J; O Brien, S; Greene, R
CUMH, Cork, Ireland
Background Accurate AC measurement is the cornerstone of assessment of fetal growth, with growth restriction contributing to 50% of stillbirths. The accuracy of ultrasonography is dependent primarily on operator skill. Aims The aim of the review was to investigate the current standard of NCHD AC measurement in the ANC setting. Methods AC measurements were accumulated over one month from NCHDs in CUMH ANC. These images were reviewed and scored by a senior consultant in maternal and fetal medicine. Results Of images collected; 3% of SHO, 12% junior registrar, and 6% of SpRs had all four features. Many had only 2/4 required for accurate AC measurement. The majority of AC sizes were underestimated with only 16-23% of NCHDs having acceptable cursor placement. NCHDs were surveyed on their knowledge of AC measurements; between 69 and 92% of NCHDs knew which features to include in an AC image. Seventy-seven percent of NCHDs regularly performed AC measurement in clinic with 62% reporting patients often request it. Sixty-nine percent of NCHDs had low satisfaction with their own AC measurement. The majority (92%) of NCHDs believed high competency in ultrasound was essential for their day-to-day practice. One hundred percent desired more formal training and a recognised ultrasound qualification to be encompassed into HST training. Seventy-seven percent of NCHDs described their current level of training in ultrasound to be inadequate. Conclusion NCHDs are regularly requested to perform biometry in ANC and desire/require additional formal training in this unit.
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Audit and analysis of SGA babies missed during antenatal surveillance Turner, S; Hugh, O; Gardosi, J Perinatal Institute, Birmingham, UK Objective Improved antenatal detection of small-for-gestationalage (SGA) fetuses is the key aim of the growth assessment protocol (GAP). We set out to undertake an analysis of the main reasons why babies born SGA are being missed antenatally. Method GAP-SCORE is a web-based audit tool provided as part of the GAP program, designed to assist review of clinical care against RCOG, NHSE, and GAP guidelines. Cases for entry are selected randomly at unit level and are fully anonymised. The cohort included 5783 cases of SGA newborn not recognised antenatally, recorded in 77 UK hospitals from 2015 to 2018. Results The largest category (41.3%) was high-risk pregnancies where SGA had not been recognised despite serial scanning; 15.4% were high risk but had no serial scans, and 25.6% were low risk but had one or more growth scans which nevertheless failed to pick up that the fetus was SGA. 17.6% of the cases were low risk where fundal height measurement failed to identify the need for a scan. The average number of scans in pregnancies designated 'high risk' at booking was 2.6 (SD: 1.5) with a mean interval of 18 days between last scan and delivery. Conclusion The study showed that many missed cases are due to fewer scans than recommended in high-risk pregnancies, probably because of chronic shortages of ultrasound resources. Less than a fifth of cases were due to lack of recognition of SGA by serial fundal height measurement in low-risk cases.
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Surface vascular placental mapping with virtual endoscopy (sonofetoscopy): qualitative comparison of singleton and monochorionic twin pregnancies Dall'Asta, A 1,2 ; Paramasivam, G 1 ; Shaw, C 1,3 ;
Objective There are limited data on the antenatal ultrasound (US) assessment of the placental vascularity. In this study, we sought to evaluate the feasibility of the antenatal assessment of the placental vascularity using three-dimensional (3D) US with Doppler and to qualitatively characterise its features. Design Nonconsecutive series of singleton and monochorionic (MC) twin pregnancies with anterior placenta referred to a single Fetal Medicine Unit. Methods B-mode transabdominal US using multifrequency volumetric (4-8 MHz) transducers was performed, and power Doppler was applied to map the intraplacental vascularisation. 3D colour volumes were obtained from a section comprising the largest diameter of the placenta and processed using rendering technologies with flow. Results Overall, 3 singleton and 3 MC diamniotic twin pregnancies, of whom one was treated with laser fetoscopy due to twin-to-twin transfusion syndrome and one complicated by selective fetal growth restriction (sIUGR), were included. The median gestational age at examination was 21 +6 (16 +0 -27
+6
). In all cases, 3D US with flow allowed clear visualisation of the cord insertion and the main vascular branches on the fetal surface of the placenta. In MC twins, the vascular anastomoses as well as the unequal vascular supply in the case of sIUGR could be demonstrated with 3D US with flow. Conclusion Antenatal evaluation of the surface placental vascularity using 3D US with Doppler is feasible. This technique, if prospectively tested, may be of value for planning in complicated MC twin pregnancies requiring fetoscopic treatment.
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Antenatal detection of SGA and false-positive rates in the GAP programme Turner, S; Williams, M; Hugh, O; Gardosi, J Perinatal Institute, Birmingham, UK Objective To investigate the effect of implementation of the growth assessment protocol (GAP) on antenatal detection of small-for-gestational-age (SGA) babies. Design Analysis of prospectively collected audit data. Method The data were based on anonymised information from 96 NHS Trusts and Health Boards in the GAP programme that entered postnatal data routinely between 2015 and 2018. Detection rate (DR) was defined as the proportion of SGA neonates that had an ultrasound estimated fetal weight (EFW) <10th centile. DR with 95% confidence intervals (CI) was calculated. False-positive rate (FPR) was defined as the proportion of fetuses with an EFW <10th that were not SGA at birth. Results Background In fetal lung conditions such as congenital diaphragmatic hernia (CDH) and cystic pulmonary airway malformation (CPAM), normal lung tissue is compressed. The reduced fetal lung volume and altered lung maturation lead to neonatal morbidity and mortality; however, patient outcomes vary according to the pathology. Changes in lung signal intensity (SI) on magnetic resonance imaging (MRI) reflect altered lung development, and may provide further insight into disease pathology and prognosis. Aim To evaluate patterns in lung SI in CDH and CPAM lungs over gestation on T2-weighted images in cases with and without lung pathology. Methods A retrospective study of 26 CPAM, 51 CDH, and 21 control patients who had attended for fetal MRI. The average lung SI was calculated using a region of interest tool for contralateral, ipsilateral, and cystic lungs. The SI ratio of the contralateral: ipsilateral lung was calculated. Regression analysis and analysis of covariance were performed. Results SI ratio significantly increased over gestation in CDH, but no change was seen in the controls or CPAM. No significant differences were found between contralateral lungs in controls, CPAM, and CDH. Despite compression, the ipsilateral lung in CPAM followed the same pattern as controls. In CDH, ipsilateral SI significantly decreased with gestation, suggesting lung hypoplasia. Inter-and intra-observer agreement was excellent. Conclusion Fetal lung compression affects lung development differently, depending on the pathology. Lung compression results in a hypoplastic ipsilateral lung in CDH; however, in CPAM the ipsilateral lung develops normally. Contralateral lungs develop normally in both CDH and CPAM.
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Accurately identifying the small-for-gestational-age fetus: determining the ideal method for our population in NHS Tayside Grzybek, A; Orr, K; Nicoll, A NHS Tayside, Dundee, UK Objectives To determine which method of assessing fetal growth is most accurate at predicting the small-for-gestational-age (SGA) infant. Design Retrospective review of women having induction of labour (IOL) for suspected SGA. Methods The maternity case notes and the last ultrasound scan prior to birth were reviewed. SGA was defined as fetal abdominal circumference (AC) <10th centile by Chitty, estimated fetal weight (EFW) <10th centile on GROW charts, or AC <10th centile on Intergrowth 21st charts. The actual birthweight (ABW) customised centile was calculated. AC and ABW from the same group were plotted on Intergrowth 21st charts. Results Eighteen women were identified. Using GROW, 8 of 18 (44%) infants were truly SGA. Chitty population AC alone predicted only 1 SGA infant. EFW as plotted on population charts identified 7 SGA. EFW and GROW identified all true SGA. However, 10 women could have avoided IOL. Using Intergrowth 21st charts, 3 of 18(17%) would have been classified as true SGA. Using AC as plotted on Intergrowth 21st charts, only 6 of 18 (33%) women required IOL for suspected SGA. Twelve women could have avoided IOL. Conclusions Using GROW charts or Intergrowth to predict the SGA fetus in our population requires intervention in 2 women to accurately identify 1 SGA fetus. Use of GROW charts would lead to greater intervention and subsequent diagnosis of SGA. Nearly 6 times as many women would be induced for suspected SGA using GROW charts than if Intergrowth 21st charts were used.
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The value of fetal magnetic resonance imaging in the prediction of short-term outcome in giant omphalocele Objectives To establish the impact of lung volume, omphalocele size, and liver herniation calculated from fetal magnetic resonance images on the short-term outcome of cases prenatally diagnosed giant omphaloceles. Design A retrospective study. Methods MR images of 14 fetuses imaged over a 7-year period (October 2011 -October 2018 were assessed for lung volumes, omphalocele volume, size of defect, abdominal circumference and omphalocele circumference, and volume of liver herniated. The short-term outcome was obtained from hospital notes and the data interrogated to assess for predictors of outcome.
Results The ratio of the observed over expected lung volume had no correlation to the omphalocele volume but did correlate with the volume of liver herniated. There was no correlation of lung volume and mortality, although the cases where the baby died had slightly lower lung volume as a group than when they survived but this was not statically significant and not predictive for individual cases. There was no correlation between the amount of liver in the omphalocele and mortality, but there was a general trend, not statistically significant, for increased mortality with increased volume of liver herniation. Conclusion There were no specific indicators that predicted shortterm outcome in this cohort. Background Doppler assessment of the umbilical artery (UA) is now made routinely for many third-trimester scans. The middle cerebral artery (MCA) Doppler is being increasingly assessed. The cerebroplacental ratio (CPR), an assessment of relative cerebral redistribution, is also being increasingly calculated. Low CPR has been associated with adverse outcomes, although its role, especially in the normally grown fetus, remains subject to debate. For each parameter, several reference ranges have been published. Methods Routinely collected UA, MCA, and CPR measurements from singleton pregnancies between 28 and 40 weeks of gestation between October 2017 and October 2018 were analysed. Women with complications of pregnancy, for example diabetes/PET, were excluded. Only fetuses between 65th and 90th centile were included as these could not be considered SGA or growthrestricted. One-way ANOVA was used. Results Fifth centile for CPR at LTHT is significantly higher than that published by Baschat (P = 0.027) although not different to Ebbing (P = 0.74). MCAPI 5th centile values are not significantly different from values published by Ebbing, although are higher than values published by Bahlmann. UAPI 95th centile values are not significantly different to values published by Ebbing or Ciabanu (P > 0.05). For both UA and MCAPI, our values are significantly different from the unpublished Schaffer graphs available on Viewpoint 6. Conclusions There is good agreement between our 'normal' population and some recent published data. However, some published charts do not reflect our population. As clinical decisions are increasingly being based on Doppler parameters, obstetricians should be aware of the variance between charts and ensure appropriate charts are used.
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Review of the utility of 30 and 36 week growth scans to detect SGA/IUGR at a large tertiary maternity unit Background Small-for-gestational-age (SGA) or growth-restricted (IUGR) fetuses are at increased risk of stillbirth and neonatal morbidity. Routine ultrasound screening has been shown to have limited utility in detecting SGA/IUGR. Nevertheless, current RCOG guidance recommends routine serial scans for women deemed at increased risk. At LTHT, we offer these women scans at 30 and 36 weeks of gestation. Methods A retrospective analysis of routinely collected data of all women with singleton pregnancies who were referred for growth scans due to low PAPP-A, IVF, maternal age ≥40 or BMI ≥35, between October 2017 and October 2018 was performed. We reviewed whether a fetus was <10th centile EFW or had a raised UA PI (>95th centile) at each scan.
Results There was a median of 2 scans in each group. Objectives Previous data have demonstrated an increased incidence in congenital lung malformations (CLM) over recent years. This supports a hypothesised a link with maternal obesity, an ever-increasing epidemiological problem. This association has yet to be demonstrated. Design A retrospective case-control study of all cases of CLM identified from a tertiary fetal medicine unit . Method For each diagnosis of a baby diagnosed antenatally with CLM, two controls were selected (the birth immediately preceding and following the affected baby). Maternal and fetal demographics were collected from electronic records, including a height and weight measurements from the initial first-trimester appointment.
Results Complete data were collected for 114 women. The average body mass index (BMI, kg/m 2 ) of all women was 25.5 (17.5-43.6 AE 5.2), and the women in the affected pregnancies had a greater BMI (26.7 AE 5.2 (n = 38)) than the control women (24.7 AE 4.7 (n = 76)) (P = 0.04). 60.5% (n = 46) of women in the control group and 39.5% (n = 15) women in the CLM group had a normal BMI (<25 kg/m 2 ). Using the proportion of women with a normal BMI compared with the number of women with a BMI above 25 kg/m 2 (case vs controls), there is a 1.53 relative risk of having an affected baby (P = 0.02, 95% CI 1.05-2.24).
Conclusions Raised BMI in pregnancy is associated with increased rates of CLM. Although causation is yet unproven, studies including genotyping and lipid profiling should be undertaken. Preconceptual weight-reduction advice is beneficial in overweight women. This is especially prudent as evidence behind the, 'developmental fetal origins', hypothesis increases.
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Long Objectives The early fetal environment is extremely important and research indicates that weight at birth can have crucial impacts on the individual's health later in life. With the current childhood obesity epidemic, we aimed to investigate whether children born macrosomic (birthweight > 4 kg) remained larger than normal birthweight infants up to 5 years of age. Design This is a longitudinal follow up of macrosomic and normal birthweight participants born into the ROLO randomised control trial in the National Maternity Hospital, Dublin, followed up at 5 years of age. Method A total of 387 participants (53% with macrosomia, 47% normal birthweight) were followed up at 5 years of age. Birthweight was previously recorded, and at the 5 years of age, child height, weight, anthropometric, and skinfold measurements were collected. Body mass index (kg/m 2 ) and centiles were calculated. Student's t-tests and Mann-Whitney U-tests were used ª 2019 The Authors. BJOG An International Journal of Obstetrics and Gynaecology ª 2019 RCOG together with multiple linear regression to control for confounders.
Results Children born macrosomic had consistently higher weights, lengths, and BMI centiles, together with increased head and chest circumferences, compared to normal birthweight children at 5 years of age (P < 0.01 for all). After controlling for child sex, intervention group, smoking during pregnancy, maternal education status, and maternal BMI, children with macrosomia were 0.61 kg heavier than nonmacrosomic infants at 5 years of age (95% CI: 0.04-1.18, P < 0.05).
Conclusions Children born macrosomic remain heavier and larger into childhood. This highlights the need for monitoring and potential interventions, both during pregnancy and in infancy, to curb the current childhood obesity crisis.
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Review of scans performed at ≥36 weeks of gestation in a large tertiary maternity unit Background Small-for-gestational-age (SGA) fetuses may have increased perinatal morbidity or mortality, particularly if growthrestricted. Ultrasound assessment is also recommended for many women presenting with third-trimester concerns. Low cerebroplacental ratio (CPR) has been associated with adverse outcomes, although the optimal management of these fetuses, especially if of apparently normal size (appropriate for gestational age/AGA), remains unclear. Early-term delivery may be recommended for small or compromised fetuses. Methods We performed a retrospective analysis of routinely collected data (estimated fetal weight (EFW), umbilical artery PI (UAPI), middle cerebral artery PI (MCA PI), and CPR) from all singleton fetuses scanned beyond 36 + 0 gestation between October 2017 and October 2018. Women with diabetes were excluded. Results One hundred and seventy-five fetuses <10th centile were detected for the first time at ≥36 weeks. A total of 4262 scans were performed in 3782 women with fetuses with EFW >10th centile. Forty-nine (1.3%) fetuses had raised UAPI >95th centile. One hundred and sixty (4%) fetuses had normal UAPI with MCPI <10th centile. Three hundred and eighty-four (13%) fetuses had normal UAPI, normal MCAPI, but CPR <5th centile. Conclusions In women being scanned at >36 + 0 for concerns about fetal growth or wellbeing,~5% fetuses may be SGA. In AGA fetuses, 13% have low CPR (despite 'normal' UA and MCA PI). The management of this group is unclear; acting on CPR may result in intervention including induction and early-term delivery in~1 in 7 scanned fetuses. In such cases, individualised assessment is required until further research clarifies the risks/ benefits to the mother and fetus. Objectives To determine the indication of iatrogenic delivery of infants born between 34 + 0 and 36+ weeks of gestation and its impact on maternal and neonatal outcomes following the introduction of customised growth charts (GAP). Methods All women with singleton pregnancies who were induced between 34 + 0 and 36 + 6 weeks between 01/08/2016 and 31/07/2017 at Forth Valley Royal Hospital were included. Data collected included indication of delivery, gestation, mode of delivery, abdominal circumference (based on population data), and customised estimated fetal weight centile and growth velocities. Birthweight (both customised and population) and neonatal outcomes were identified. Results Ninety-eight women were identified. A major indication for delivery was suspected fetal growth restriction (45%). The majority of women had an SVD (64.2%). 40% required admission to neonatal care. 54.5% of women induced for IUGR delivered SGA babies on personalised birthweight charts; this is a falsepositive rate of 31% with a 0% false-negative rate. If we use a sexspecific population birthweight centile, 20.4% delivered SGA babies; this was 47% of the cases identified as ACs <10th centile, resulting in 53% false-positive rate and a 5% false-negative rate. Conclusions This shows the relatively high rates of neonatal morbidity associated with LPTB. Of concern is the high falsepositive rate of SGA of babies identified on ultrasound using both customised and population data. Further evaluation of customised versus population growth charts and EFW versus AC growth velocity is required to guide clinicians in timing of delivery to minimise unnecessary intervention in LPTB group. Objectives The aim of the study was to prospectively gather data on the outcomes of prenatally diagnosed life-limiting conditions in a large tertiary referral centre. Method Data were gathered prospectively in a large tertiary referral centre over 5 years from 2013 to 2017 inclusively. We defined life-limiting conditions as conditions where the baby was predicted to die before or shortly after birth. Outcomes including termination of pregnancy (TOP), miscarriage, intrauterine death (IUD), and neonatal death were recorded. Results There were a total of 44,750 deliveries in the study period. There were 1836 congenital anomalies diagnosed in the study period including 163 cases (8.8%) of life-limiting conditions. Full outcome data were available in 94 cases. 63 (67%) women chose a TOP following the diagnosis. There were 9/94 (9.5%) second-trimester miscarriages and 11/94 (11.7%) IUDs. The total fetal loss rate in those that did not undergo termination was 20/31 65%. There were 10/31 (32%) neonatal deaths with 1/ 94 (1%) baby surviving the early neonatal period. Conclusion Life-limiting conditions are encountered frequently in fetal medicine. This study was based in a unit where termination of pregnancy for fetal anomalies requires travel to another jurisdiction, providing a unique opportunity to observe the natural history of these conditions. In this study, in 99% of cases babies did not survive beyond 4 weeks of life. 65% died before birth, and 35% died in the early neonatal period. Accurate outcome data are beneficial when counselling those with a diagnosis of a life-limiting condition. Women were asked to rate each question 1-10, 1 (least anxious) and 10 (most anxious). Results were collated and analysed. Women were also given the chance to give free comments about their experience.
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Results Twenty-five women received the survey. The response rate was 100%. When women were told there was a potential problem with first baby, their median score was 9. They scored their anxiety at 8, when arriving at FMD. During the scan, the median score was 8. While I the department, after score women reported anxiety as 5. After leaving the department, women reported a score of 8 at home. Conclusion Women were most anxious prior to and during their scan. Immediately after scan, women's anxiety was at the least. However, after leaving the FMU anxiety levels returned and require further investigation of how best to keep these reduced. Objectives The nuchal translucency (NT) measurement is offered to all pregnant women during antenatal screening. Any measurement above 3.5 mm is considered raised and we wanted to investigate the outcomes of theses pregnancies. Design All pregnancies between June 2016 and June 2018 with a NT >3.5 mm were identified and included. Methods Fifty-seven pregnancies were identified. The NT measurements ranged from 3.6 to 16.8 mm, with a median measurement of 4.7 mm. The data on pregnancy outcomes were obtained from the electronic maternity records and ViewPoint.
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Results Of these 57 pregnancies, 3 miscarried and 11 opted for termination. All pregnancies which were terminated had a chromosomal abnormality, except 1 case with a diaphragmatic hernia and cardiac abnormalities. There were 3 cases of intrauterine fetal demise among this group (at 20, 22, and 41 weeks of gestation). The earlier gestation pregnancies were known to have significant abnormalities on scan. Thirty-four of the 57 pregnancies resulted in the birth of a healthy infant. We present a case of ileal injury and ischaemia following laser treatment for twin-to-twin transfusion syndrome (TTTS) masquerading as twin anaemia polycythaemia sequence (TAPS). Case A 35-year-old Para 0 with MCDA twins had fetoscopic laser ablation for stage III TTTS at 19 weeks. The donor fetus had absent umbilical cord EDF and an absent a-wave in the ductus venosus at diagnosis. The fetoscopic procedure was challenging due to poor visualisation from old blood stained liquor. The pregnancy was subsequently monitored with weekly ultrasound assessments and progressed with two surviving fetuses with normal Doppler parameters until 26 weeks of gestation when one twin developed ascites and an elevated (> 1.5 MOM)middle cerebral artery peak systolic velocity (MCA -PSV). Fetal blood sampling was performed with a view to progressing to intrauterine transfusion for TAPS. The fetal haematocrit was normal. The working diagnosis for the ascites was revised to a bowel perforation, and the pregnancy was managed conservatively until delivery was indicated shortly thereafter by placental abruption. The fetal MCA-PSV measurements remained discordant until delivery. The baby with antenatal ascites underwent laparotomy on day 2, which demonstrated an ileal perforation, surgery aided a steady recovery. Discussion Babies surviving TTTS may develop rarely reported complications such as ischaemic injuries to limbs and intestines. The exact aetiologies behind these complications are unknown, but theories include mesenteric ischaemia due to hypoperfusion or hyperviscosity (depending on whether donor or recipient affected), haemodynamic alterations, or emobolic phenomena following laser treatment. Objective To determine whether previous pregnancies with an SGA fetus, or pregnancies with obstetric complications, are risk factors for SGA or growth restriction in a prospective cohort of suspected IUGR pregnancies. Design The PORTO study recruited 1200 ultrasound-dated singleton IUGR pregnancies, defined as EFW <10th centile (Hadlock IV, 1985) , between 24 + 0 and 36 + 6 weeks of gestation, with serial sonographic assessment of fetal weight and multi-vessel Doppler studies until birth. Delivery outcomes and pregnancy complications from up to six previous pregnancies were analysed for risk or SGA (birthweight < 10th centile) or pathological growth restriction (absent/reversed flow in the umbilical artery Doppler or a pulsatility index > 95th centile), in the index pregnancy. Results Delivery outcome from previous pregnancies was available in 513 IUGR pregnancies. A total of 333 (65%) of the index pregnancies resulted in an SGA fetus, 226 (44%) had an abnormal UA, and 175 (34%) were SGA with an abnormal UA during the pregnancy. There was a higher risk for SGA if the prior pregnancy resulted in an SGA fetus (RR = 1.17, P = 0.025) or if any previous pregnancy resulted in SGA (RR = 1.22, P = 0.002). However, SGA in a previous pregnancy was not associated with pathological growth restriction in the index pregnancy. Prior preterm delivery was strongly associated with preterm delivery in the index pregnancy (RR = 2.6, P < 0.001). Conclusions Maternal history of SGA or preterm delivery is a risk factor for SGA or preterm delivery in a subsequent pregnancy. However, these were not associated with a higher risk for pathological growth restriction in our study population.
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The Results We report the positive and salient negative results in our exome cohort to date (in excess of 30 cases). The molecular diagnosis rate is currently 29% including mutations in CHD7, PIEZO1, PTPN11, BICD2, SLC26A2, UBE2A, SLC6A9, LZTR1, and RMRP. We report the outcomes of all pregnancies having undergone exome sequencing, some of which are currently ongoing. Conclusions Our diagnostic rates are consistent with those in the published literature. Our in-house testing has provided a molecular diagnosis in a time frame that allows prospective parents to make a more informed decision about the management of their pregnancy. Fetal hydrops appear to be over-represented in the group with positive exome findings.
EP.160 T2 and T2* placental magnetic resonance imaging in pre-eclampsia (PE) and chronic hypertension (CHTN Magnetic resonance imaging (MRI) offers potential for noninvasive high-resolution multimodal in vivo placental assessment, combining structure and function measures using T2-weighted imaging and T2* relaxometry, respectively. The magnetic field inhomogeneities from paramagnetic deoxyhaemoglobin with spin-spin relaxation (T2) is termed T2*, providing a measure of oxygenation. Hypothesis: MRI will identify a placental phenotype in PE and CHTN. Methods Prospective observational cohort study. Women were imaged in a clinical 3T Philips Achieva scanner with 32-channel cardiac coil. Long TE T2-weighted tubo spin echo sequence and T2*multi-echo gradient echo, echo planar imaging were performed. T2* maps were calculated using MATLAB and whole placenta manually segmented using ITK-SNAP. Results Thirty-six controls (21-38/40), 19 CHTN women (19-38/ 40), and 7 PE women (27-34/40) were imaged, 6 twice during pregnancy. T2-weighted imaging showed increasing placental lobularity with gestation with a homogenous granular appearance in controls, advanced lobularity in PE and CHTN, varied lobule size with heterogenous granularity, and substantial areas of low signal intensity in PE. Placental mean AE SD T2*(ms) values are shown in Table 1 . For birthweight < 3rd centile, mean T2* was lowest with reduced active fraction (fraction of voxels >0.9*maximum T2* value) for a given gestation. Conclusion These preliminary data identify a placental phenotype in PE and CHTN. T2* relaxometry has potential to identify placental dysfunction and subsequent fetal growth restriction. Objectives The MERIDIAN study aimed to establish whether fetal MRI improves the accuracy of diagnosis of fetal developmental brain abnormalities following ultrasound screening. Nested within this multicentre clinical trial, a qualitative study was conducted to describe, explore, and understand 1) women's views about the acceptability of iuMR imaging in service-user perspectives of PND for brain anomaly and 2) the acceptability of iuMR imaging in PND for brain anomaly, from a service-provider perspective as well as 3) draw on health professionals' views about potential barriers and facilitators for developing policy and provision, should the trial outcomes suggest there is a case for enhancing UK service provision. Design and methodology Qualitative mixed methods study of patients consisting of surveys and in-depth interviews; two rounds of interviews with clinicians Results and conclusions Social issues are often neglected in the implementation of new technologies in fetal medicine, and in addressing this gap, our findings uncover similar and complementary insights from both these groups of stakeholders. Our study highlighted three main issues detailing the advantages and disadvantages of iuMRI in PND for brain anomaly: Accessibility, Triangulation and Quality Assurance. In addition to this, we present implications for policy development that have the potential to impact patient experience and enhance professional engagement with whatever cost-effective national provision framework is implemented. These include a better appreciation of the needs of the pregnant patient, clear and transparent reporting of iuMR images, appropriately timed access to iuMR imaging and more professional collaborative working across fetal medicine and radiology.
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A retrospective audit and qualitative analysis into the antenatal uptake of free fetal DNA testing for rhesus D-negative mothers Brehaut, G; Bain, E; Halawa, S Musgrove Park Hospital, Taunton, UK Introduction In England and Wales, approximately 17% of women are Rhesus D(RhD)-negative. Routine antenatal anti-D prophylaxis(RAADP) should be recommended to RhD-negative mothers. Free fetal DNA(ffDNA) can establish fetal rhesus status. Objectives To audit the process of RhD testing and administration. To identify uptake of antenatal ffDNA testing. To identify potential reasons why patients decline ffDNA testing. To prevent unnecessary administration of a blood product. Design Retrospective data analysis and telephone survey. Method All mothers who had been detected as Rhesus-negative on antenatal screening during a 12-month period were identified. Laboratory samples were cross-referenced to identify uptake rates of ffDNA typing. Maternal notes were reviewed to establish antenatal practice and compared against predefined audit standards. The results of a telephone survey were collated to better understand the patient interpretation of counselling in rhesus disease and offer of ffDNA test. Results 34% were offered ffDNA testing, and, of those, 32% accepted. 12% had the offer of written information documented. 33% received RAADP, and then, babies were confirmed rhesusnegative. 96% had anti-D given appropriately. 99% had rhesus status checked and documented at delivery. 45% of patients completed the telephone survey. 28% were offered ffDNA testing and 22% felt it was explained. 18% thought they were given written information.
Conclusion Women are not being adequately counselled regarding antenatal options and may be receiving unnecessary blood products. Healthcare professionals need to improve discussions surrounding ffDNA to allow informed decision-making and improve patient care.
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Once upon a thymus -a rare story of fetal thymic hyperplasia Richardson, H; Bradnock, R; Ledingham, MA Queen Elizabeth University Hospital, Glasgow, UK A 27-year-old Para 1 with a booking BMI of 17 was referred to a tertiary fetal medicine centre for assessment of an unusual fetal mediastinal mass. She had screened low chance for Down syndrome; however, a low PAPP-A (0.18) was identified and serial third-trimester growth scans had been organised. Her fetal anomaly scan was unremarkable. She attended for a planned growth scan at 31 weeks of gestation. While the growth was normal, a hypoechogenic area superior to the heart measuring 17 9 30 9 28 mm was identified. Cardiac views were normal, and there was no evidence of fetal hydrops. She was referred to a tertiary fetal medicine centre for further assessment of a suspected CPAM. Review at fetal medicine confirmed the scan findings, and a fetal MRI was organised. Images confirmed the presence of a prominent thymus in the prevascular space. The patient was subsequently reassured and returned to community midwife care. She went into spontaneous labour at 39 + 1 weeks of gestation and had an uncomplicated SVD of a male infant. Few cases of antenatally detected fetal thyroid enlargement exist. This case demonstrates that it can often be misinterpreted for a pathological mediastinal mass. Differential diagnoses include CPAM and fetal teratoma. Fetal MRI can often provide further valuable clinical information. Massive thymic hyperplasia is a rare finding with only a few documented cases. The aetiology is unknown and most cases are detected postnatally when the child can present with symptoms of respiratory distress and cardiomegaly is seen on a chest X-ray. Objective To investigate the potential performance of screening for term-PE by the addition of inhibin A to that of various combinations of maternal factors, mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI), placental growth factor (PLGF), and soluble fms-like tyrosine kinase-1 (sFLT-1) at 35-36 weeks of gestation. Study design This was a case-control study drawn from a screening study at 35 + 0 À36 + 6 weeks. Inhibin A was measured in 50 cases that subsequently developed PE and 200 controls that did not develop any hypertensive disorder of pregnancy. Bayes' theorem was used to combine the prior distribution of the gestational age at delivery with PE, obtained from maternal characteristics, with various combinations of biomarker multiple of the median (MoM) values to derive the patient-specific risks of delivery with PE. Results In pregnancies that developed PE, compared to those without PE, MoM values of inhibin A, MAP, UtA-PI, and sFLT-1 were increased and PLGF was decreased. Addition of inhibin A improved the performance of screening for PE by maternal factors and by a combination of maternal factors and PLGF; there was also a nonsignificant trend for improved performance of screening by maternal factors, MAP and PLGF, and by maternal factors, MAP UtA PI and PLGF. The performance of screening by maternal factors, PLGF and inhibin A, was similar to that of maternal factors, PLGF and sFLT-1. Conclusion Inclusion of serum inhibin A could potentially improve the performance of third-trimester screening for term-PE, but this needs to be investigated further by prospective screening studies.
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Impact of the new definition of pre-eclampsia on the incidence of the disease Khan, N; Andrade, W; Zumaeta, AM; de Castro, H; Nicolaides, K King's College Hospital NHS Foundation Trust, London, UK Background The traditional definition of pre-eclampsia (PE) is based on the development of hypertension and proteinuria. This has recently been revised to include cases without proteinuria but with evidence of renal, hepatological, or haematological dysfunction. Objective To examine the impact of the new definition of PE on the incidence and severity of the disease. Methods This was a retrospective study of singleton pregnancies delivered in two maternity hospitals between March 2006 and June 2018 and classified as PE or gestational hypertension (GH) according to the traditional criteria. We reviewed the records of GH, and the cases with high creatinine or liver enzymes or low platelet count were reclassified as PE. The gestational age at delivery and incidence of small-for-gestational-age (SGA) neonates and perinatal death in the groups of PE according to traditional criteria (A), PE according to new criteria (B) and GH (C) were compared.
Results The study population of 6273 pregnancies included 2860 in group A, 298 in group B, and 3115 in group C. The increase in incidence of PE according to the new criteria was 9.4%. The median gestation at delivery was 38.4, 39.6, and 39.8 weeks, incidence of SGA was 35.1%, 20.8%, and 20.6%, and incidence of perinatal death was 1.8%, 1.0%, and 0.5% for groups A, B and C, respectively. Conclusion In terms of gestational age at delivery and incidence of SGA and perinatal death, pregnancies with PE according to the new criteria resemble those with GH rather than traditional PE. Objective This is a case report demonstrating the importance of fetal intervention in the circumstance of a large CPAM with fetal hydrops. CPAM is a rare developmental abnormality of the lung arising from an overgrowth of the terminal bronchioles.
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Study design This is a case of left-sided CPAM picked up at 21/ 40 gestation in a 28-years-old G2P1 patient. At diagnosis, the lesion was 4.5 9 2.9 cm. The heart was displaced with no hydrops. No other structural abnormalities or soft markers were identified. At 23 + 2/40, the CPAM was 5.4 9 3.8 cm, the heart was displaced, and hydrops had developed. The lesion appeared macrocystic. At 25 + 2/40, a thoracoamniotic shunt was placed. By 26 + 2/40, the hydrops had almost completely resolved. By 27 + 2/40, the CPAM had started to enlarge again. At 28 + 2/40, a reshunt was placed. Four days later, the cysts were no longer visible and however were replaced by a solid component of similar size. Gradually, over the next few weeks the CPAM became smaller and the heart was less deviated.
Results At 36 + 3/40, a SROM occurred and a caesarean section was performed following an APH. The infant required no resuscitation. On day 10, the baby became increasingly tachypnoeic and was transferred to the paediatric hospital where the cardiothoracic surgeons performed a lobectomy removing the CPAM. The infant was extubated on day 2 and was discharged home on nocturnal oxygen 3 weeks postsurgery. Conclusion The infant is now one year old and is developmentally normal, and his only ongoing treatment is nocturnal oxygen.
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Uterus didelphys with a spontaneous dicavity twin pregnancy Schaler, LT; Petch, SS; Martin, AA Coombe Women and Infants University Hospital, Dublin, Ireland
Objective M€ ullerian duct abnormalities are extremely rare and have an incidence of 5%. These malformations may lead to the formation of a uterus didelphys. The incidence of a dicavity twin pregnancy in parturients with uterus didelphys is reported to be 1 in 1,000,000. There are few cases reported to date; however, these high-risk pregnancies are known to be complicated by miscarriage, preterm labour, and preterm rupture of membranes.
Study design Here, we present the case of a 24-yr nulliparous woman with a newly diagnosed uterus didelphys and a spontaneous conception of a dicavity twin pregnancy. A double uterus, double cervix, and single vagina were found on ultrasound at 9 weeks of gestation. A renal ultrasound revealed a single kidney. On vaginal examination, a single cervix was identified. The pregnancy progressed without complication to 24 weeks of gestation where both fetus' were found to be SGA. There was AEDF in the smaller twin which subsequently progressed to intermittent REDF by 27 weeks of gestation but then reverted back to AEDF. An elective caesarean section was performed at 34 + 2 weeks of gestation.
Results The parturient underwent a planned caesarean section with a Pfannensteil incision and lower transverse uterine incision. There was no connection between the two uteri. Each uterus had a single tube and ovary. Birthweights were 1.74 kg and 1.64 kg, respectively. Conclusion Dicavity pregnancies in cases of uterus didelphys should be managed in tertiary obstetric centres with close antenatal consultant-led care, and the timing of delivery should be planned to avoid potential complications at delivery. Mosaicism occurs when two or more chromosomally distinct cell lines arising from a single zygote are detected in an individual. In approximately 1-2% of pregnancies, chromosome abnormalities are detected only in the placenta and not the fetus, defined as confined placental mosaicism (CPM). Method A 43-year-old woman in her fourth pregnancy was referred to the fetal medicine unit following a high-risk firsttrimester screening result; fetal nuchal translucency measured 3.5 mm, and risk of trisomy 21 was 1 in 40. Of note, her first child died at one month of age and all subsequent investigations to determine an underlying cause were inconclusive. A chorionic villus sample (CVS) was obtained at 13 + 3 weeks of gestation. Results Quantitative fluorescence polymerase chain reaction (QF-PCR) analysis demonstrated mosaic trisomy 21. As the clinical significance was unclear, the patient attended for amniocentesis at 15 + 1 weeks of gestation. QF-PCR analysis of amniotic fluid confirmed trisomy 18 (Edward's syndrome). Additional G banded chromosome analysis (karyotype) of the CVS sample showed an abnormal female karyotype of 48 chromosomes, trisomic for chromosomes 21 and 22 (48, XX, +21, +22) consistent with CPM. Retrospective review of the QF-PCR result for the CVS sample revealed low level peaks in keeping with trisomy 18 cell line. Conclusion Interpretation and clinical management of mosaic results are challenging. Confirmatory amniocentesis is recommended following a mosaic finding. Multidisciplinary collaboration between the genetics laboratory and fetal medicine is essential to ensure timely and appropriate management of conflicting results.
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What is the relationship between change in estimated fetal weight centile and fetal growth velocity? Owen, M; Owen, P Princess Royal Maternity Hospital, Glasgow, UK Objective To determine whether change in estimated fetal weight centile (DEFWc) is statistically closely related to fetal growth velocity EFW (FGVEFW). Design FGV represents a methodologically sound technique of quantifying fetal growth but is not widely adopted. DEFWc is readily calculated but is methodologically limited since it relies on cross-sectional data. This pilot study describes the statistical relationship between DEFWc and FGVEFW among a cohort of lowrisk pregnancies undergoing ultrasound at predetermined intervals. Method We identified 50 consecutive cases from a previously described data set. EFWc was calculated from an online calculator at fetalmedicine.org. FGVEFW was calculated according to existing methodology. DEFWc and FGVEFW Z scores were calculated over 28-day intervals for two gestational age ranges, 30-32 to 34-36 weeks (A) and 33-36 to 37-40 weeks (B). The statistical relationship between DEFWc and FGVEFW was described by correlation coefficients and determined by BlandAltman limit of agreements. Results Mean DEFWc and FGVEFW Z score were À15.8 and À0.1, respectively (GA range A), and À4 and 0.1 (GA range B). Scatter plots illustrate the relationship between DEFWc and FGVEFW. The correlation coefficients were 0.7 at GA range A, and 0.27 at GA range B. Bland-Altman plots identified no agreement between DEFWc and FGVEFW at either GA range. Conclusion When growth is quantified over a 28-day interval, DEFWc was found not to be correlated with FGVEFW. Further study is required to determine the method of quantification of fetal growth, which has greatest clinical utility in identifying the growth-restricted fetus. various specialties involved in management of these cases prenatally and postnatally. Results Thirty-five respondents completed survey. This included fetal medicine practitioners (49%), paediatric urologists (22%), neonatologists (11%), paediatric surgeons, and nephrologists (11%). Around 85% of the responses indicated availability of local protocols and guidelines. Follow up was arranged when renal anteroposterior diameter (APD) was 5-10 mm, according to 20%. One third arrange for one postnatal scan, while others routinely arrange 2 scans. There was wide variation in age of the baby at the first (birth-1 month) and the second postnatal scans (when it was done). The threshold of APD in postnatal scans for continued follow up was >10 mm in half the response, but in the other half, there was a wide range (7-15 mm). Nearly half said they would use prophylactic antibiotics if the prenatal renal pelvic diameter was more than 10 mm, with a wide variation in the other half. Also, half of the respondents would stop antibiotics if the first postnatal scan showed resolution of hydronephrosis. Conclusions In view of wide variation, there is need for a national evidence-based guideline to standardise the practice across the UK, to avoid unnecessary investigations and treatment of neonates with unilateral hydronephrosis, and to allay parental anxiety.
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Isolated fetal hydronephrosis: sonographic predictors of adverse postnatal outcome Wilkins, J; Robson, S; Lambert, H Newcastle University, Newcastle upon Tyne, UK Objectives To determine antenatal ultrasound (US) predictors of (a) significant pelvi-ureteric junction obstruction (PUJO) and (b) surgery in fetuses with apparently isolated hydronephrosis (HN) with the aim of improving prenatal counselling. Design Prospective study in one regional fetal medicine centre. Methods Fetuses with isolated HN (maximum renal pelvis antero-posterior diameter [RPAPD] ≥10 mm) were prospectively identified between 2010 and 2016 (n = 192). Data were collected on prenatal US findings and postnatal outcomes (minimum one year follow-up). Independent antenatal predictors of adverse outcome were determined using binary logistic regression. The optimal RPAPD to differentiate cases with and without significant PUJO (defined as a split function of <40% on a MAG 3 scan) and postnatal surgical intervention were determined by ROC curve analysis. Results HN resolved by birth in 46.4% and by six months of age in 77.5%. Significant PUJO was present in 7.4%; independent predictors were calyceal dilation (Odds Ratio [OR] 6.0, 95% CI 1.6-23.2), parenchymal abnormality (OR 9.0 [2.6-31.5] and RPAPD ≥15 mm ]. 11.5% of children underwent surgery with the same US predictors: 5.6 (95% CI 2.0-15.7), 8.0 (95% CI 2.5-25.2) and 10.3 (95% CI 3.3-31.6) respectively. The optimal RPAPD cut-off was 15 mm for both outcomes; sensitivity and specificity for significant PUJO was 83% and 78% respectively and for surgical intervention 86% and 69% respectively.
Conclusions Adverse postnatal outcomes are uncommon but can be predicted by antenatal features; however, this is not reliable. Children therefore remain at risk even when RPAPD remains.
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Is it time to rationalise screening for growth restriction in the third trimester? Jie, M; Morgan, K Frimley Park Hospital, Camberley, UK Objectives Poor identification and surveillance of growthrestricted babies is directly related to stillbirth and poor neonatal outcome. The national guidance used for identifying pregnancies complicated by small for gestational age (SGA) relies heavily on third-trimester serial ultrasounds. The introduction of these screening tools has increased the amount of unplanned, urgent referrals at a time of national shortage of ultrasound skills and capacity. Our data suggest poor identification of SGA despite these tools. Is it time to think again? Design & method Retrospective audit examining 100 cases from 1/03/2017 onwards at Frimley Park Hospital (FPH) -a large DGH with 5500 deliveries/year. Inclusion: singletons with a birthweight of ≤10th centile (definition of SGA). Exclusion: not booked at FPH by the third trimester. Sample identification via Euroking and simple data analysis. Results Our results demonstrate poor pick-up with over half of SGA missed. The most common indications for additional scans were GAP-indicated and reduced fetal movements. Low PaPP-A and previous SGA risk factors were poorly identified. Most SGA were identified after 34 weeks (54%). Conclusions We believe the multitude and complexity of current national guidelines hinder the identification of the at-risk SGA baby. Despite compliance with all three national guidelines, the identification is still poor. We propose that ALL women receive a formal growth assessment at 34 and 38 weeks of gestation, reserving serial ultrasound from 28 weeks to the highest risk groups only. By forward planning, this will ensure better use of ultrasound resources and more efficient identification of small babies.
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Women's choices in noninvasive prenatal testing for aneuploidy screening: results from a single centre prior to introduction in England Sacco, A 1,2 ; Hewitt, H 2 ; Pandya, P Objectives To evaluate patient choices and uptake of noninvasive prenatal testing (NIPT) for aneuploidy screening offered in an NHS foundation trust as part of routine care, prior to introduction in England.
Design Retrospective review. Method We retrospectively reviewed data for all women with a singleton pregnancy attending for routine first-trimester screening from January 2017 to June 2018. Women with a chance of trisomy 21, 18, or 13 greater than 1 in 150 ('high chance') were offered the choice of no further testing, NIPT, or invasive testing. This is in line with the modified screening pathway recommended by the UK National Screening Committee for the evaluative roll out in England. Results A total of 7939 women were included in this study. Of the 352 women with a high-chance screening result for trisomy 21, 291 women (82.7%) opted for NIPT. The proportion of women opting for NIPT decreased as the chance of trisomy 21 increased: NIPT uptake was 93.2%, 90.0%, 77.1%, and 47.2% for women with a chance of 1:100-150, 1:50-99, 1:10-49, and >1:10, respectively. At first contact, 516 women (5.5%) had already accessed screening in the private sector, and 638 women (6.8%) declined any aneuploidy screening or testing. Conclusion Implementation of NIPT testing in a contingency model appears acceptable to patients, with high uptake in a nonresearch NHS setting. Consideration should be given to widening NIPT implementation to primary screening. The main challenges are cost, informed consent, and management of 'no result'. In addition, we need to further explore patient opinions. Objectives With the advent of noninvasive prenatal testing/ diagnosis, the number of invasive procedures performed is declining. Simulation has proven beneficial for other medical scenarios; however, simulators are often expensive and not readily available in all units. This study aimed to assess the value for maternal and fetal medicine subspecialty trainees (MFM SSTs) of performing invasive procedures on a low-cost highfidelity model. Design/methods Candidates attending the RCOG MFM SST Review, October 2018, were invited to assess the amniocentesis/ feticide simulator (AmnioAbbey, Adam, Rouilly) using a P8 ultrasound machine (GE Healthcare). Questionnaires were administered assessing trainees': length of MFM training, number of fetal medicine sessions/week, number of invasive procedures performed, previous simulator use, perception of the model's realism, and potential benefit to training. Results Eight of 15 MFM SSTs agreed to participate. Trainees had 8-36 months of MFM training (median 17), procedures undertaken ranged from 36 to 170 (median 42). Two of eight trainees had previously used a fetal medicine simulator. On a scale of 1-10 (10 being most useful), the overall value was rated 7 (range 5-9). One participant did not give a score. Useful aspects included needle tracking, simulating the maternal abdomen and skin texture. Less realistic features included abnormal shadowing, the placenta, and uterine texture. Conclusions Overall, most MFM SSTs found this model to be beneficial particularly in practicing needle tracking. Only 25% of participants had previously had access to a fetal medicine simulator; increasing their use may be beneficial to MFM SSTs in the future, particularly at the beginning of their training. Background Although maternal perception of reduced fetal movements (RFMs) is associated with adverse pregnancy outcomes, most pregnancies with RFM end in the birth of a healthy infant and excessive intervention may be detrimental.
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ReMIT-2 is a multicentre pilot randomised controlled trial (RCT), which aims to assess whether a definitive trial is feasible and provide proof of concept that informing care by measurement of placental growth factor (PlGF) improves pregnancy outcome following RFM. Test validation To inform trial design, a systematic review of diagnostic test accuracy (DTA) studies was undertaken and identified that low PlGF had a sensitivity of 69-100% and a specificity of 33-75% to predict stillbirth (4 studies, 5894 participants). A DTA study of women with RFM ≥36 weeks of gestation (n = 295) found ultrasound estimated fetal weight<10th centile had a sensitivity of 24% and a specificity of 95% to predict adverse pregnancy outcome; adding PlGF measurement increased sensitivity to 38% and specificity to 84%. Trial design The additional sensitivity achieved by inclusion of PlGF, although modest, was deemed acceptable by both the patient and public involvement (PPI) group and trial steering committee. The PPI group were instrumental in developing standardised information for potential participants, including a video and leaflet. To date, 166 women have been recruited and the views of participants about test performance will be included in the study assessment.
Conclusions Developing this test-treat RCT highlights the need for robust DTA data in the population of interest and for highquality PPI to ensure potential participants receive accurate standardised information.
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Influence Significant diurnal differences existed in baseline FHR, short-term variation (STV) and long-term variation (LTV) in low-risk (FHR: P < 0.01; STV: P < 0.001; LTV: P < 0.05), but not eFGRpregnancies (FHR: P = 0.21; STV: P = 0.21; LTV: P = 0.24). Regression analysis suggested a differing relationship between time of day and STV in eFGR compared with low-risk pregnancies (P = 0.06). Conclusion This study confirms that diurnal variation exists in low-risk pregnancies but implies its absence in eFGR. This may represent blunting of the autonomic nervous system secondary to fetal decompensation. Clinically, these findings provide reassurance that cCTG interpretation in eFGR is not time-critical.
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The overburdened district general fetal medicine clinic: a clinical audit and service evaluation Stace, C; Halawa, S Introduction Fetal cardiac tumours are rare with an incidence of 1/20,000 births of which cardiac rhabdomyoma (CR) is the most common. CR is often the earliest sign of tuberous sclerosis (TS), which is a rare AD genetic disorder with benign tumours in the brain, heart, kidneys, skin, and/or eyes. Case Thirty-year-old primigravida with no significant medical/ familial history was found to have irregular fetal left ventricular outline at 20 weeks' scan. Further scans at FMU suggested 31mmx28 mm mass around left ventricle with small pericardial effusion. She was referred to Bristol where she had fetal MRI. Baby was closely monitored with fortnightly ultrasound scans and was delivered at 39 +1 weeks by ElCS for unstable lie. A baby boy of 3.7
Kg was born in good condition needing no respiratory support or surgical intervention. MRI brain done 4 weeks after delivery showed widespread tubers involving the cortex and white matter confirming TS, echocardiogram showed a large LV rhabdomyoma with mild LV impairment not needing treatment, and ECG showed few benign ectopics. The child is now 1 year old on medication for infantile spasm and has poliosis of the eyelashes of right upper eyelid as the only cutaneous manifestation of TS.
Conclusions Tumour size >20 mm and haemodynamic instability are poor prognostic markers that may cause fetal cardiac dysrhythmias and hydrops. Once CR is detected in utero, close surveillance is essential during pregnancy and postdelivery to diagnose TS and the extent of visceral involvement. Prenatal counselling and genetic screening for the child and family members should be offered.
EP. Objectives Twin-to-twin transfusion syndrome (TTTS) is a condition with high perinatal mortality, optimally treated by fetoscopic laser ablation (FLA) to maximise fetal survival and reduce morbidity. We have published our data of prenatal predictors of outcomes relating to at least one survivor (2011) . Since this period, we use the Solomon technique of FLA, performed by additional operators. These data assess the impact of this change and the prenatal predictors of the outcome of dual fetal survivors. Methods Pregnancy outcomes were collected from monochorionic twin pregnancies complicated by severe TTTS (≤26 completed weeks) treated by FLA (2015-18) for the dualsurvivor analysis. Logistic regression analysis compared outcomes with changes in technique over time and with introduction of new operators. Results For 2015-2107, dual-survivor rate was 47% and survival rate of ≥1 twin was 86%, and Quintero stage 3 disease correlated with a reduction in dual-survivor outcome in the multiple logistic regression model . Experience and use of Solomon technique as predictors of survival did not show a significant correlation with dual-survivor outcomes. For 2017-2018, the overall fetal survival post-FLA was 74.5% comprising single survivors in 34% of pregnancies, dual survivor in 57.4%, and a pregnancy loss rate of 8.6%. Conclusions Severe TTTS treated by FLA leads to at least dual survivors in up to 57% of cases. New operators achieve good outcomes with support from the original surgeons.
EP.190
Accuracy of estimated fetal weight using obstetric ultrasound Brehaut, G; Halawa, S; Corker, J Musgrove Park Hospital, Taunton, UK Introduction An accurate assessment of fetal growth is necessary in obstetric care. RCOG and NICE both recommend serial fetal growth measurements for high-risk pregnancies. Objectives To ensure appropriate antenatal and delivery care, it is vital that EFWs are reliable when compared to actual birthweight (ABW). We wanted to analyse accuracy of EFW in Musgrove Park (MPH) and assess potential influencing factors. Design Retrospective data analysis using the trust scanning database and birth registration database. Method A total of 726 cases were identified over 9 months. Inclusion criterion was that delivery was within 7 days from scan. All gestations were included. The EFW was compared against ABW, and the percentage difference was calculated. An acceptable margin of error(AME) was 10%. The data were divided into categories to analyse whether they affected accuracy. These included gestation at scan, birthweight, BMI, and method of EFW calculation. Results 82.8% of ABWs were within 10% of the EFW. 78.9% of preterm deliveries had an ABW within 10% of EFW compared to 83.9% >37 weeks. Hadlock (HC-AC-FL) improved accuracy compared to Hadlock (AC-FL) with 84.5% within the AME versus 81.5%. Maternal BMI of 35. 100% of scan EFWs were within 10% of ABW when this was 4000 g. Conclusions Ultrasound predicted EFW is accurate even at term and with raised BMI. Healthcare professionals who perform fetal growth scans require adequate training and audit of images to ensure accuracy.
EP.191
Visualisation of the fetal bowel on T1-weighted magnetic resonance imaging scans Hyde, G 1 ; Fry, A 2 ; Whitby, E Objective We aimed to examine the correlation between antenatal 2D ultrasound estimation of placental surface area and volume, placental weights at delivery, and maternal plasma placental growth factor (PlGF). Study design Prospective cohort study conducted by a single researcher in a tertiary centre. Method Consenting women had maternal plasma PlGF quantification at two gestational time points; between 19 and 22 weeks and again between 32 and 34 weeks, using the Triage â PlGF Test. Ultrasound scans were carried out at the same time as PlGF testing. Placental thickness and diameter were measured in longitudinal and transverse planes. Placental surface area and volume estimation were calculated using these measurements. Postnatal placental volume was calculated using water displacement method. Correlations of the PlGF measurements at each trimester with the placental measurements were calculated. Results Ninety-five women were recruited. No correlation was noted between PlGF and placental surface area or placental volume on antenatal ultrasound at either 19-22 weeks or 32-34 weeks. No correlation was noted between PlGF and placental weight or volume at delivery. Conclusion Gestational PlGF does not appear to correlate well with antenatal ultrasound assessment of placental surface are or volume or with placental weight or volume at delivery.
EP.193
Trends in fetal anomaly screening over 15 yrs in a single unit Tydeman, G; Clegg, I NHS Fife, Kirkcaldy, UK Objectives To determine trends in rates of prenatally diagnosed fetal anomaly, diagnosis of diagnosis, and false-positive rates over 15 yrs in a single unit. Design Retrospective analysis of prospectively collected data. Method All fetal anomalies are entered into a local database at the time of diagnosis with outcomes entered within a year of delivery. Results There have been steady rises in prenatal suspicion of anomaly since 2003 when there were 11.9 anomalies/booker until 2017 with 34.9 anomalies/booker. In 2003, 83% of anomalies were identified at a low-risk anomaly scan, whereas in 2017, this was 32% and for the first time, lower than the number identified at the booking scan (42%) even though there was no policy to screen for anomalies at that scan. False positives were defined as those anomalies that turned out to have no clinical significance for the baby and did not mean the diagnosis was incorrect as included renal pelvis dilation, increased NT, and other conditions known to resolve sometimes. The overall false-positive rate was 31% and is presented by anatomical system. for example when a cardiovascular anomaly is suspected, 70% of the time it will be significant but only 61% if abdominal. Conclusions There are significant trends in the detection of fetal anomaly despite constant policies, which can be used to target workforce needs and patient expectation. False-positive rates by anatomical system are presented that provide useful tools in counselling women faced with the suspicion of anomaly.
EP.194
Efficacy of antenatal corticosteroids for preventing neonatal respiratory distress syndrome in twin pregnancies at risk of preterm birth: systematic review and meta-analysis of randomised and observational data Young, C; Bhattacharya, S University of Aberdeen, Aberdeen, UK Objective To assess the efficacy of ACS administration for preventing neonatal respiratory distress syndrome (RDS) in twin pregnancies at risk of preterm birth. Background Although antenatal corticosteroid (ACS) administration for neonatal lung maturity in singleton births is widely accepted, the evidence for their use in twin pregnancies is weak. Method Medline, PubMed, Embase, and Cochrane library were searched using the following terms: (corticosteroids OR adrenal cortex hormones) AND (twin pregnancy OR multiple pregnancy) AND (neonatal complications OR respiratory distress syndrome) without restrictions. Studies were eligible if they compared corticosteroid versus no corticosteroid or placebo in twin pregnancies and reported the neonatal outcome of RDS. Pooled risk ratios with 95% confidence intervals were calculated using RevMan software, version 5. Quality of included studies was assessed using the Downing and Black checklist. Results Of the 4995 papers identified, 18 studies were included. Data from 13 observational studies (23551 participants) showed reduced risk of neonatal respiratory distress syndrome (RDS) (pooled RR 0.85 95% CI 0.76 to 0.96) with corticosteroid administration. However, the pooled risk ratio from 5 randomised controlled trials (participants = 1347) did not show any significant difference in risk (RR 0.96 95% CI 0.79 to 1.15). Conclusion Although pooled observational data do show a marginal effect of ACS in preventing neonatal RDS, the same effect is not seen in RCTs. Based on this systematic review and meta-analysis, there does not appear to be any beneficial effect of corticosteroid administration in preterm twins using the current therapy regime. correlation of antenatal 2D ultrasound estimation of placental surface area (SA) and volume with postnatal placental measurements and neonatal birthweight. This prospective cohort study examined 277 singleton pregnancies in a tertiary centre. Scans were carried out at 10-14, 18-22, and 32-34 weeks. Placental thickness and diameter were measured in longitudinal and transverse planes. Placental SA and volume estimation were calculated using the measurements. Standardised images of the delivered placentas were taken and placental SA calculated digitally. Postnatal placental volume was calculated using water displacement method. Correlations of the antenatal estimates in each trimester with the postnatal measurements and birthweight were calculated. A positive correlation was found between postnatal placental SA and birthweight (r = 0.47, P < 0.001). SA estimated at the second trimester was the most strongly related of all three scans estimates to the postnatal SA (r = 0.30, P < 0.001). A strong positive correlation was also found between placental volume at delivery and birthweight (r = 0.59, P < 0.001). The volume estimated at the third trimester was the most strongly correlated of all three scan estimates to the postnatal placental volume (r = 0.26, P < 0.001). Placental SA and volume at delivery are strongly related to birthweight. Estimating these on antenatal ultrasound is challenging, with only moderate correlation at the secondtrimester scan for SA and in the third-trimester scan for placental volume. Larger studies are needed as the antenatal ultrasound measurements can potentially be used as a predictive tool for fetal growth restrictions.
EP.195
EP.196
The fetal origin of adult disease extending beyond the first generation: a possible explanation of why that is so Dixckson, MJ The Barker hypothesis demonstrated -and explained how -the fetal response to placental insufficiency leads to developing various diseases in later life. Such conditions include vascular disease, hypertension, and type 2 diabetes. What is less well known is that the second (F2) generation can be affected by the adverse fetal environment of the first generation (F1). And there is no explanation for this observation. We report a case where a woman developed severe pre-eclampsia in her first pregnancy, associated with a small-for-gestational-age (SGA) baby. Prior to pregnancy the woman had essential hypertension and type 2 diabetes. She also had a cerebrovascular accident in her late 20s. The baby was born at 33 weeks weighing on the 1st centile. So, highly likely in later life to develop the variety of condition associated with the Barker hypothesis.
On questioning the woman, she herself was born very small for gestational age. So, we can assume her disease burden was likely enough a consequence of the insulin resistance she developed in utero as an SGA baby. We believe this case report illustrates how maternal hypertension caused by growth restriction of that woman when a fetus, can then be a risk factor for her developing pre-eclampsia when she is an adult. Which in turn causes growth restriction of her fetus with the chance of that infant developing disease in adult life because of its mother being SGA.
EP.197
An assessment of UCC students' knowledge of fatal fetal anomaly and termination of pregnancy for fetal abnormality Devine, D Objective The objective of this study is to assess UCC students' knowledge of fatal fetal anomaly (FFA) and termination of pregnancy for fetal abnormality (TOPFA). Design This descriptive study was conducted with UCC students. Data were collected using an online questionnaire. The survey consisted of fact-based questions with a view to ascertaining the knowledge level of students around FFA and TOPFA. Methods UCC students registered for the academic year 2017-2018 were included in this study. In total, 20,106 students received the survey and 520 answered the survey, 478 of which were completed responses. Results 99.62% (519/521) were comfortable with the topic, while only 0.38% (2/521) were uncomfortable with the topic and terminated the survey. Almost half (48%; 232/479) correctly defined FFA. A small number (6%; 28/476) of students thought Down syndrome is a FFA while only 24% (117/478) could identify Patau syndrome as a FFA. 8% of students considered cerebral palsy to be a FFA, and 16% thought Spina Bifida is a FFA. Major disparity was obvious around survivability with a diagnosis of FFA; 13% thought a baby will not survive once born, while 16% believed a baby can survive for years. Conclusion Deficits in knowledge were identified in accurately defining FFA, survivability, services made available to couples, and classification of FFAs. This gap in student knowledge stresses the need for more readily available and accurate public health and college education campaigns, especially now with legislation about to be introduced to allow TOPFA in Ireland for the first time.
